Inventor · disambiguated record
Mark W. Feinberg
Also filed as: FEINBERG MARK · FEINBERG MARK W
9 granted patents·7 pending applications·9 citations·filing 2003–2023
80Inventor score
Files withBRIGHAM & WOMENS HOSPITAL INC6FEINBERG MARK W4BRIGHAM & WOMENS HOSPITAL2THE BRIGHAM AND WOMEN’S HOSPITAL INC2ONCOIMMUNIN INC1
Top patents by PatentIndex Score
16 records- 0180US9790552B2Detection of organ rejectionBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Oct 17, 2017·2 cites·12 claims
- 0272US8691572B2Diagnosing, monitoring and treating inflammationFEINBERG MARK W·Filed 2009·Granted Apr 8, 2014·2 cites·1 claims
- 0371US12428410B2Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Granted Sep 30, 2025·0 cites·8 claims
- 0471US8906875B2Methods of treating vascular inflammatory disordersFEINBERG MARK W·Filed 2011·Granted Dec 9, 2014·3 cites·10 claims
- 0564US9500658B2Kruppel-like factor 10 (KLF10) as a biomarker of endothelial progenitor cell dysfunctionFEINBERG MARK W·Filed 2012·Granted Nov 22, 2016·2 cites·14 claims
- 0661US2024417726A1miRNA REPROGRAMMING OF SMOOTH MUSCLE CELLS INTO ENDOTHELIAL CELLSTHE BRIGHAM AND WOMEN’S HOSPITAL INC·Filed 2022·Application pending·0 cites
- 0761US2025230230A1Treatment of perivascular fibrosis and other hypertensive diseases and conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2023·Application pending·0 cites
- 0858US11267807B2Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Mar 8, 2022·0 cites·16 claims
- 0956US2009263830A1Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markersONCOIMMUNIN INC·Filed 2009·Application pending·0 cites
- 1055US2003211548A1Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markersONCOLMMUNIN INC·Filed 2003·Application pending·0 cites
- 1153US9534219B2Methods of treating vascular inflammatory disordersTHE BRIGHAM AND WOMEN S HOSPITAL INC·Filed 2014·Granted Jan 3, 2017·0 cites·9 claims
- 1249US2022010310A1An lncRNA integrates a DNA-PK-mediated DNA damage response and vascular senescenceBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Application pending·0 cites
- 1348US10260067B2Enhancing dermal wound healing by downregulating microRNA-26aBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Apr 16, 2019·0 cites·14 claims
- 1446US9322015B2Methods of using microRNA-26a to promote angiogenesisFEINBERG MARK W·Filed 2012·Granted Apr 26, 2016·0 cites·8 claims
- 1546US2014194340A1Diagnosing, monitoring and treating inflammationBRIGHAM & WOMENS HOSPITAL·Filed 2013·Application pending·0 cites
- 1646US2010086928A1Detection of organ rejectionBRIGHAM & WOMENS HOSPITAL·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark W. Feinberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →